Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Immunogenicity of an Inactivated Split-virion H1N1 Vaccine
NCT01336166Phase 2Completed
- Sponsor
- Shanghai Institute of Biological Products
- Start
- Jul 2009
- Primary completion
- Jul 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of inactivated split-virion 2009 pandemic influenza a h1n1 vaccine in influenza A H1N1 infection (H1N1), sponsored by Shanghai Institute of Biological Products. Started Jul 2009; status: completed.
02
Drugs
inactivated split-virion 2009 pandemic influenza a h1n1 vaccine
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT01336166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336166.